Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma

被引:26
作者
Nagata, K
Hirono, S
Ido, A
Kataoka, H
Moriuchi, A
Shimomura, T
Hori, T
Hayashi, K
Koono, M
Kitamura, N
Tsubouchi, H [1 ]
机构
[1] Miyazaki Med Coll, Dept Internal Med 2, Miyazaki 8891692, Japan
[2] Miyazaki Med Coll, Dept Pathol 2, Miyazaki 8891692, Japan
[3] Mitsubishi Tokyo Pharmaceut Inc, Yokohama Res Ctr, Yokohama, Kanagawa, Japan
[4] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan
基金
日本学术振兴会;
关键词
HGF; HGFA; serine protease; HAI-1; serine protease inhibitor; hepatocellular carcinoma; chronic hepatitis; liver cirrhosis;
D O I
10.1006/bbrc.2001.5916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor activator inhibitor type I (HAI-1), a Kunitz-type serine protease inhibitor for hepatocyte growth factor activator (HGFA), is responsible for proteolytic activation of hepatocyte growth factor. We examined the expression of HGFA and HAI-1 in liver tissues of chronic liver diseases including hepatocellular carcinoma (HCC). HGFA expression was detected not only in the liver tissues of chronic hepatitis and cirrhosis and in the nontumorous liver tissues surrounding HCC, but also in HCC tissues. On the other hand, none of the liver tissues of hepatitis and cirrhosis and none of the nontumorous tissues surrounding HCC were stained with anti-HAI-1. However, 35% of HCC tissues were stained with anti-HAI-1, and HAI-1 positivity increased as the histological grade decreased and as serum a-fetoprotein increased. Transduction of antisense HAI-1 inhibited the growth of human hepatoma cells. These results suggest the possibility that HAI-1 plays an important role in the progression of HCC. (C) 2001 Academic Press.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 47 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]   Hepatocyte growth factor scatter factor activates the apoptosis signaling pathway by increasing caspase-3 activity in Sarcoma 180 cells [J].
Arakaki, N ;
Kazi, JA ;
Kazihara, T ;
Ohnishi, T ;
Daikuhara, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (01) :211-215
[4]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[5]   The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice [J].
Bell, A ;
Chen, QY ;
DeFrances, MC ;
Michalopoulos, GK ;
Zarnegar, R .
ONCOGENE, 1999, 18 (04) :887-895
[6]  
BOIX L, 1994, HEPATOLOGY, V19, P88, DOI 10.1002/hep.1840190115
[7]   PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS [J].
BOUCHET, C ;
SPYRATOS, F ;
MARTIN, PM ;
HACENE, K ;
GENTILE, A ;
OGLOBINE, J .
BRITISH JOURNAL OF CANCER, 1994, 69 (02) :398-405
[8]  
Burr AW, 1996, HEPATOLOGY, V24, P1282
[9]   Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c-met does [J].
DErrico, A ;
Fiorentino, M ;
Ponzetto, A ;
Daikuhara, Y ;
Tsubouchi, H ;
Brechot, C ;
Scoazec, JY ;
Grigioni, WF .
HEPATOLOGY, 1996, 24 (01) :60-64
[10]   Induction of apoptosis by hepatocyte growth factor scatter factor and its augmentation by phorbol esters in meth A cells [J].
Gohda, E ;
Okauchi, H ;
Iwao, M ;
Yamamoto, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (01) :278-283